insulin
Cold Chain RequiredFDA Approved, EMA Approved
Description
Recombinant human insulin is used for the treatment of diabetes mellitus and has been utilized in Mitchell-Riley syndrome, a rare disorder characterized by neonatal diabetes and intestinal atresia. Patients with Mitchell-Riley syndrome require lifelong insulin therapy due to pancreatic beta-cell dysfunction. Insulin regulates glucose metabolism by facilitating cellular glucose uptake.
Indications & Therapeutic Use
diabetes mellitus type 1, diabetes mellitus type 2, neonatal diabetes, Mitchell-Riley syndrome
Linked Diseases:
Mitchell-Riley syndrome
C567570
Global Availability (11 countries)
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
insulin
| Generic Name | insulin |
| Brands | 1 brand available |
| Active Ingredient | recombinant human insulin |
| Drug Class | diabetes mellitus type 1 |
| Manufacturer | Eli Lilly |
| Dosage Forms | subcutaneous injection, 100 units/mL; IV infusion |
| Medical Code | A10AB01 |
| Orphan Status | No |
| Cold Chain | Required |
| Lead Time | 3 days |
| Reg. Status | FDA Approved, EMA Approved |
| Clinical Trial | NCT02984228 |
| Countries | 11 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations12 Validated Nodes